Altis Biosystems, Inc. has a human stem cell technology which recreates both the small and large intestinal epithelium for drug screening and microbiome research for pharmaceutical and biotechnology companies. Altis' goal is to reduce the time and cost of drug development with a platform that more accurately reflects native human biology.
Altis sells its platform by both providing contract research services and selling it as a product for use in customer facilities. Altis provides a variety of contract research services, including permeability, toxicology, protein/gene expression, immunohistochemistry, high-content imaging, secretory assays by ELISA, co-cultures, and more.
RepliGut® Custom Services